4.5 Article

RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA

期刊

MOLECULAR PHARMACOLOGY
卷 65, 期 1, 页码 252-256

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.65.1.252

关键词

-

资金

  1. NIGMS NIH HHS [GM07623] Funding Source: Medline
  2. NIMH NIH HHS [MH34007] Funding Source: Medline
  3. NINDS NIH HHS [NS35891] Funding Source: Medline
  4. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH034007, R37MH034007] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035891] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The human serotonin 5-HT2C receptor undergoes adenosine-to-inosine RNA editing at five positions, generating multiple receptor isoforms with altered G-protein coupling properties. In the current study, we demonstrate that RNA editing regulates the pattern of intracellular signaling. The non-edited human 5-HT2C receptor isoform INI activates phospholipase D via the G(13) heterotrimer G-protein. We present evidence that transactivation of the small G-protein RhoA is required for phospholipase D activation. In contrast, neither transactivation of RhoA nor phospholipase D activation was detected in cells expressing the fully edited VGV isoform. The ability to activate phospholipase C is also reduced in VGV-expressing cells, but not to the extent found for the phospholipase D signal. We conclude that RNA editing represents a novel mechanism for regulating 5-HT2C receptor signaling to pathways linked to actin cytoskeletal organization and regulated exocytosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据